Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Nathalie Dekeersmaeker"'
Autor:
Martine Dauwe, Koen De Geyter, Manu Vandijck, Filip Dekeyser, Geert Jannes, Pieter Van Hecke, Paul Vandeponseele, Roger Moonen, Vesna Kostanjevecki, Nathalie Dekeersmaeker
Publikováno v:
Alzheimer's & Dementia. 14
Autor:
Jean A. Bernatchez, K. Van Laethem, Kris Covens, Ricardo Jorge Camacho, Anne-Mieke Vandamme, Lore Vinken, Nathalie Dekeersmaeker, Sarah Megens, Matthias Götte, Kristof Theys, S De Wit
Publikováno v:
Acta Clinica Belgica. 69:348-357
The amino acid position 70 in HIV-1 reverse transcriptase (RT) plays an important role in nucleoside RT inhibitor (NRTI) resistance. K70R is part of the thymidine analog mutations, but also other amino acid changes have been associated with NRTI resi
Autor:
Sarah Megens, Frederic Rousseau, Dolores Vaira, Guangdi Li, Nathalie Dekeersmaeker, Kristel Van Laethem, Joost Schymkowitz, Anne-Mieke Vandamme, Yoeri Schrooten, Michel Moutschen, Greet De Baets
Publikováno v:
Virology. :310-318
We investigated the origin and the effect of insertion D67D-THGERDLGPA within HIV-1 RT from a patient failing antiviral therapy. The insertion developed within the context of pre-existing NRTI and NNRTI mutations (M41L, L210W, T215Y and N348I). Concu
Autor:
Jorge Luis Tórtora Pérez, Carlos Fonseca, Orlando Martínez, Nathalie Dekeersmaeker, Anne-Mieke Vandamme, Kristel Van Laethem, Delmis Álvarez, Lore Vinken, Yudira Soto, Vivian Kourí, Yeisel Abrahantes, Consuelo Correa, Yoeri Schrooten, Jorge Campos, Gertjan Beheydt, Lissette Pérez, Stijn Imbrechts, Alina Álvarez, Yoan Alemán, Carlos Aragonés
Publikováno v:
Infection, Genetics and Evolution. 16:144-150
In Cuba, antiretroviral therapy rollout started in 2001 and antiretroviral therapy coverage has reached almost 40% since then. The objectives of this study were therefore to analyze subtype distribution, and level and patterns of drug resistance in t
Autor:
Delmis Álvarez, Vivian Kourí, Stijn Imbrechts, Nathalie Dekeersmaeker, Daniel Pérez, Jorge Luis Tórtora Pérez, Lore Vinken, Kristel Van Laethem, Carlos Aragonés, Carlos Fonseca, Yudira Soto, Alina Álvarez, Anne-Mieke Vandamme, Yoan Alemán, Lissette Pérez, Consuelo Correa, Jorge Campos, Gertjan Beheydt, Yoeri Schrooten
Publikováno v:
Journal of Clinical Virology. 55:348-355
a b s t r a c t Background: Emergence of HIV-1 drug resistance may limit the sustained benefits of antiretroviral therapy (ART) in settings with limited laboratory monitoring and drug options. Objectives: Surveillance of drug resistance and subtypes
Autor:
Stéphane De Wit, Nathalie Dekeersmaeker, Sarah Megens, Kristel Van Laethem, Kris Covens, Anne-Mieke Vandamme, Kabamba Kabeya, Jan Balzarini
Publikováno v:
Antiviral Research. 86:253-260
Mutations that are selected at low frequency and/or reside outside the enfuvirtide target region, amino acid 36–45 of gp41, might still be important determinants for drug resistance. This study aimed to investigate the phenotypic impact against enf
Autor:
Dominique Schols, Kris Covens, Jan Weber, Anne-Mieke Vandamme, Nathalie Dekeersmaeker, Kristel Van Laethem, Yoeri Schrooten, Miguel E. Quiñones-Mateu
Publikováno v:
Journal of Clinical Microbiology. 47:2232-2242
Combination therapy can successfully suppress human immunodeficiency virus (HIV) replication in patients but selects for drug resistance, requiring subsequent resistance-guided therapeutic changes. This report describes the development and validation
Autor:
Kabamba Kabeya, Anne-Mieke Vandamme, Nathalie Dekeersmaeker, Eric Van Wijngaerden, Yoeri Schrooten, Kristel Van Laethem, Kris Covens, Stéphane De Wit
Publikováno v:
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology. 44(4)
Background: Enfuvirtide is active against isolates from different HIV-1 subtypes. In vitro and in vivo studies reveal that resistance mutations are primarily found within the region spanning amino acid 36–45 of gp41. However, most studies include o
Autor:
Eric Van Wijngaerden, Marc Van Ranst, Nathalie Dekeersmaeker, Kris Covens, Kristel Van Laethem, Yoeri Schrooten, Anne-Mieke Vandamme, Paul De Munter
Publikováno v:
Journal of virological methods. 153(2)
Recently, the Food and Drug Administration (FDA) of the USA approved the first integrase inhibitor for inclusion in treatment regimens of HIV-1 patients failing their current regimens with multi-drug resistant strains. However, treatment failure has
Publikováno v:
Journal of clinical microbiology. 45(9)
Human respiratory syncytial virus (HRSV) is the leading viral cause of severe respiratory illness for infants and young children worldwide. Two major antigenic groups (A and B) of HRSV exist, and viruses from both subgroups can cocirculate during epi